A separate study showed EphA2 is present in glioma stem cells, wherein it enables ligand-dependent signalling facilitated by ephrin-A1 via Akt and ERK suppression, and ligand-independent Akt signalling via phospho-S897, which was inhibited by the ligand. The gene discussed is AKT1; the disease is central nervous system cancer.